DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

ImmunoGen (NASDAQ: IMGN)

14.01 -0.26 (-1.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $14.01 -1.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.31
Previous Close $14.27
Daily Range $14.00 - $14.31
52-Week Range $5.34 - $15.88
Market Cap $1.2B
P/E Ratio -21.55
Dividend (Yield) $0.00 (0.0%)
Volume 902,202
Average Daily Volume 2,623,659
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

Why ImmunoGen Inc.'s Stock Soared Today

Shares of the struggling biopharma ImmunoGen skyrocketed today following a clinical update at the American Society of Clinical Oncology meeting. Here's what you need to know moving forward.

10 Best Biotech Stocks in the NASDAQ

5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary

ImmunoGen's IMGN529 for B-Cell Malignancies Demonstrates Synergistic Activity with Rituximab in Prec

ImmunoGen's IMGN529 for B-Cell Malignancies Demonstrates Synergistic Activity with Rituximab in Preclinical Models of Non-Hodgkin Lymphoma

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

ASCO Event Analyzer - 2015's Winners And Losers

Top-Performing Biotech and Drug Stocks During ASCO '15

Immunogen: Defeating Advanced Ovarian Cancer And Other Malignancies

ImmunoGen Surges on Positive Ovarian Cancer Study Data - Analyst Blog

ASCO - Surprise Boost For ImmunoGen In Ovarian Cancer

Strength Seen in ImmunoGen (IMGN): Stock Soars 71.9% - Tale of the Tape

See More IMGN News...

IMGN's Top Competitors

IMGN $14.01 (-1.82%)
Current stock: IMGN
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB